GLOBAL BLOOD THERAPEUTICS IN's ticker is GBT and the CUSIP is 37890U108. A total of 247 filers reported holding GLOBAL BLOOD THERAPEUTICS IN in Q3 2022. The put-call ratio across all filers is 0.56 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $238,000 | -45.8% | 3,500 | -74.5% | 0.01% | -37.5% |
| Q2 2022 | $439,000 | -7.8% | 13,750 | 0.0% | 0.01% | +14.3% |
| Q1 2022 | $476,000 | +51.1% | 13,750 | +27.9% | 0.01% | +75.0% |
| Q4 2021 | $315,000 | -13.2% | 10,750 | +21.5% | 0.00% | -20.0% |
| Q4 2018 | $363,000 | -8.1% | 8,850 | -14.9% | 0.01% | 0.0% |
| Q3 2018 | $395,000 | -2.5% | 10,400 | +16.2% | 0.01% | 0.0% |
| Q2 2018 | $405,000 | +0.5% | 8,950 | +7.2% | 0.01% | 0.0% |
| Q1 2018 | $403,000 | – | 8,350 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Alerce Investment Management, L.P. | 356,270 | $24,262,000 | 23.36% |
| Twin Securities, Inc. | 376,669 | $25,651,000 | 11.94% |
| Paradigm Biocapital Advisors LP | 1,175,879 | $80,077,000 | 10.68% |
| Chicago Capital Management, LLC | 246,246 | $16,769,000 | 9.12% |
| HARVEST MANAGEMENT LLC | 141,500 | $9,636,000 | 7.78% |
| Fernwood Investment Management, LLC | 174,724 | $11,899,000 | 5.02% |
| ArchPoint Investors | 168,725 | $11,490,000 | 4.69% |
| HAVENS ADVISORS LLC | 46,000 | $3,133,000 | 4.69% |
| Perceptive Advisors | 2,322,247 | $158,145,000 | 4.59% |
| Crabel Capital Management, LLC | 112,680 | $7,674,000 | 4.48% |